申请人:Takahashi Makoto
公开号:US20050211954A1
公开(公告)日:2005-09-29
A 4-aminopyridinium compound is represented by the formula (I) or (II).
in which each of L
1
and L
3
is —O—CO—, —CO—O—, —C≡C—, —CH═CH—, —CH═N—, —N═CH— or —N═N—; L
2
is a single bond, —O—CO—, —CO—O—, —C≡C—, —CH═CH—, —CH═N—, —N═CH— or —N═N—; m is 0 or 1; each of p and q is 1 to 10; each of R
1
and R
2
is an alkyl group or R
1
and R
2
are combined to form a ring; Z is cyano, an alkyl group, an alkoxy group, an acylalkyl group, an acylalkoxy group, an acyloxyalkyl group or an acyloxyalkoxy group; each of R
3
, R
4
and R
5
is a halogen atom; each of n1, n2 and n3 is 0 or 1; and X is an anion.
4- 氨基吡啶化合物由式 (I) 或 (II) 表示。
其中每个 L
1
和 L
3
是-O-CO-、-CO-O-、-C≡C-、-CH═CH-、-CH═N-、-N═CH-或-N═N-; L
2
是单键、-O-CO-、-CO-O-、-C≡C-、-CH═CH-、-CH═N-、-N═CH-或-N═N-;m 是 0 或 1;p 和 q 各是 1 至 10;R
1
和 R
2
是烷基或 R
1
和 R
2
是氰基、烷基、烷氧基、酰基烷基、酰基烷氧基、酰氧基烷基或酰氧基烷氧基;R
3
, R
4
和 R
5
是卤素原子;n1、n2 和 n3 各为 0 或 1;以及 X 是阴离子。